<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date19726225.6 (espacenet)  (Federated)  (European Patent Register), 20190422
Patent/reg. no. and dateDK/EP 3784663, 20230712
Publication date20210303
Priority no. and dateUS 201862661525 P, 20180423
EP pub. no. and date EP 3784663 20210303
Effective date
Applicant/ownerCelgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US
Applicant ref. no.P82884DK01
InventorALEXANDER, Matthew, D., 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
CARRANCIO, Soraya, 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
CORREA, Matthew, D., 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
GRANT, Virginia Heather, Sharron, 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
HANSEN, Joshua, 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
HARRIS, Roy, L., 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
HUANG, Dehua, 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
KERCHER, Timothy, S., 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
LOPEZ-GIRONA, Antonia, 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
NAGY, Mark, A., 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US,
PLANTEVIN-KRENITSKY, Veronique, 10300 Campus Point Drive, Suite 100
San Diego, CA 92121, US
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 31/454 (2006.01) , A61P 35/00 (2006.01) , C07D 401/04 (2006.01) , C07D 401/14 (2006.01) , C07D 417/14 (2006.01) , C07D 491/08 (2006.01) , C07D 491/10 (2006.01) 
TitleSUBSTITUEREDE 4-AMINOISOINDOLIN-1,3-DIONFORBINDELSER OG DERES ANVENDELSE TIL BEHANDLNG AF ET LYMFOM
Int. application no.US2019028471
Int. publication no.WO2019209692
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact